Research analysts at BMO Capital Markets boosted their price target on shares of Bristol-Myers Squibb (NYSE:BMY) from $48.00 to $51.00 in a report released on Wednesday, American Banking & Market News reports. The firm currently has a “market perform” rating on the stock. BMO Capital Markets’ price objective would suggest a potential upside of 4.17% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at TheStreet reiterated a “buy” rating on shares of Bristol-Myers Squibb in a research note to investors on Friday, October 18th. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of Bristol-Myers Squibb in a research note to investors on Friday, October 11th. Finally, analysts at Zacks upgraded shares of Bristol-Myers Squibb from an “underperform” rating to a “neutral” rating in a research note to investors on Wednesday, October 9th. They now have a $49.00 price target on the stock. One analyst has rated the stock with a sell rating, six have issued a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. Bristol-Myers Squibb presently has an average rating of “Buy” and a consensus price target of $48.10.
Bristol-Myers Squibb (NYSE:BMY) opened at 48.96 on Wednesday. Bristol-Myers Squibb has a one year low of $30.64 and a one year high of $49.57. The stock has a 50-day moving average of $42.73 and a 200-day moving average of $42.60. The company has a market cap of $80.604 billion and a P/E ratio of 60.72.
Bristol-Myers Squibb (NYSE:BMY) last released its earnings data on Wednesday, October 23rd. The company reported $0.46 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.44 by $0.02. The company had revenue of $4.07 billion for the quarter, compared to the consensus estimate of $4.02 billion. During the same quarter last year, the company posted $0.41 earnings per share. Bristol-Myers Squibb’s revenue was up 8.8% compared to the same quarter last year. Analysts expect that Bristol-Myers Squibb will post $1.73 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Friday, November 1st. Stockholders of record on Friday, October 4th will be paid a dividend of $0.35 per share. This represents a $1.40 annualized dividend and a dividend yield of 2.86%. The ex-dividend date is Wednesday, October 2nd.
Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.